• Hepatocarcinoma and cholangiocarcinoma: new treatment for liver tumors
• Liver tumors: The latest in research and clinical practice at the centre of the three international events
• Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also took part
• Hepatocarcinoma: the results of the Humanitas study published in The Lancet Oncology